地诺孕素临床应用研究进展

Research progress of dienogest in the clinical application

地诺孕素于2018年12月在中国获批应用于子宫内膜异位症的治疗,目前其已在90多个国家广泛应用,具有良好的临床疗效及低不良反应的优点,现将地诺孕素临床应用研究进展进行综述。

Dienogest was approved in China in December 2018 for the treatment of endometriosis.It has been widely used in more than 90 countries in the world,It has the advantages of good clinical efficacy and low side effects.The research progress in the clinical application of dienogest is summarized.